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Pott disease: when lumbar pain is not innocent
Abstract
Tuberculosis is a mycobacterial infection that can affect the lungs as well as other organs. The involvement of the spine, although 
rare, can have major consequences if not diagnosed and treated in a timely and effective manner, such as residual deformities 
and neurological deficits. On occasion, the atypical presentation of tuberculous spondylitis may cause a delay in treatment and 
therefore lead to less favorable outcomes. In this article, we present a rare case of progressed tuberculous infection involving the 
respiratory and musculoskeletal system in a 36-year-old patient whose main complaints were non-specific and mild, and started 
only two weeks before his diagnosis, despite the advanced disease. 
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Introduction
Tuberculosis is a common disease world-
wide, although the vast majority of cases are 
reported in developing countries [1]. Tubercu-
lous spondylitis, also known as Pott disease, is 
rare, as only 1% of all tuberculosis cases has 
involvement of the spinal column [2]. However, 
tuberculous spondylitis is considered to be the 
most dangerous type of skeletal tuberculosis, as 
it can lead to deformity of the spine and cause 
neurological deficits or pulmonary insufficiency. 
Although tuberculous spondylitis is one of the 
oldest demonstrated diseases of humankind [3], 
it can easily be overlooked as the symptoms are 
often non-specific and insidious.
Case report
A 36-year-old South Asian male with a body 
mass index of 25.3 kg/m2, presented with a per-
sistent low-grade fever, weight loss, mild lumbar 
pain and cough over a period of approximately 
2 weeks. He was a non-smoker, without known 
pathological medical condition. On clinical ex-
amination, the patient had normal blood pressure 
(120/65 mm Hg), a temperature of 37.4°C, mild 
tachycardia (102 beats/min), normal respiratory 
rate (14 breaths/min) and normal oxygen satu-
ration. The lung sounds were normal on chest 
auscultation. The clinical examination of the 
central nervous system, abdomen, cardiovascu-
lar system, and lymph nodes was also without 
pathological findings.
Routine laboratory examinations results 
were insignificant. The white blood cell count 
was normal (8560 cells/mL, 67% of neutrophils, 
22.3% of lymphocytes). His C-reactive protein 
was 2.2 mg/L. The urinalysis and urine culture for 
common pathogens were also normal. However, 
the chest radiograph on presentation showed 
diffuse alveolar infiltrates bilaterally, with an 
area of more dense consolidation and a possible 
cavitation in the right upper lung zone, as well 
as a small to medium size pleural effusion of the 
left lung (Figure 1A).
In order to clarify the exact nature of the ra-
diological findings, a chest computed tomography 
(CT) was considered appropriate. It detected areas 
of consolidation in both lungs, multiple centri-
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lobular nodules with a tree-in-bud pattern, a large 
cavitation of 5.7 cm in diameter in the right upper 
lobe, a left-sided pleural effusion and enlarged 
mediastinal and axillar lymph nodes bilaterally. 
The spectrum of differential diagnosis in-
cluded other conditions that can cause cavitary 
lesions of the lung (Table 1) [4].
At the same time, a lumbar region CT was 
performed, given the patient’s persistent lumbar 
pain (Figure 1B). It revealed multiple fractures 
in the lumbar 1 and 2 vertebrae and a stenosis of 
the intervertebral disc space with a destruction 
of the disc. No signs of spinal cord pressure were 
noted. A large cold psoas abscess was also present 
(6.3 × 4.2 × 8.5 cm).
Further laboratory evaluation was ordered. 
Sputum cultures for common pathogens were 
non-diagnostic. The tuberculin skin test (TST) 
was positive (15 mm). Sputum samples were 
collected for a full laboratory investigation for tu-
berculosis (TB), including acid-fast bacilli (AFB) 
smear, nucleic acid amplification testing and AFB 
cultures. Furthermore, the pleural effusion was 
investigated by thoracentesis. The fluid was an 
exudate with a clear predominance of lympho-
cytes (100%), and an adenosine deaminase (ADA) 
value of 59 U/mL, however, the pleural fluid sam-
ple did not provide bacteriological confirmation 
of tuberculosis. The sputum testing resulted in 
the confirmation of mycobacterium tuberculosis 
complex infection, with susceptibility to rifam-
picin (R) and isoniazid (H). The psoas abscess 
was drained under CT guidance (Figure C) and 
samples were sent for cytology, cultures for com-
mon pathogens, and AFB cultures. The results 
were also in favor of the TB infection. Testing for 
human immunodeficiency virus (HIV) infection 
was negative.
Complementary imaging of the lumbar region 
with MRI was performed so that more details 
could be obtained about the exact extent of the 
musculoskeletal involvement. In addition to the 
mentioned CT findings, a paravertebral abscess 
was discovered, in proximity to Lumbar 1 and 
2 vertebrae. 
The patient suffered from drug-suscepti-
ble TB that involved both the respiratory and 
musculoskeletal system. He had been receiving 
initially isoniazid, rifampicin, ethambutol (E), 
pyrazinamide (Z) for 2 months, and then contin-
Figure 1. A. Chest radiograph on presentation: posteroanterior view; B. lumbar region computed tomography (CT); C. CT-guided abscess drainage
A B C
Table 1. Differential diagnosis of cavitary lung disease 
Infectious diseases Neoplastic diseases Autoimmune and interstitial iiseases 
Pulmonary abscess Malignancies Granulomatosis with polyangiitis
Septic emboli Langerhans cell histiocytosis (LCH) Rheumatic nodules
Mycobacterium tuberculosis infection Lymphangioleiomyomatosis (LAM) Sarcoidosis
Non-tuberculous mycobacterial infection (NTMB) Lymphocytic interstitial pneumonia (LIP)
Aspergillosis
Pneumocystis jirovecii infection
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ued treatment with HR. The total duration of the 
chemotherapy was 18 months. No surgical treat-
ment was required, however, a lumbar support 
brace was used. The patient showed a slow but 
steady recovery over a period of several months 
after treatment.
Discussion 
With regard to the extrathoracic TB, it is es-
timated that 15% of all TB cases globally concern 
extrapulmonary forms [8]. HIV infection plays 
a key role in the increase of the extrathoracic 
incidence (Table 2) [1, 5].
Tuberculous spondylitis can present with 
non-specific symptoms such as malaise, weight 
loss and night sweats. The spine can be painful 
on movement, or during sleep. Cold abscesses are 
also frequently present.
The goals of treatment include the eradi-
cation of the mycobacteria, the stabilization of 
the spine, the prevention and/or correction of 
deformities and neurological deficits. Chemo-
therapy remains the mainstay of management. 
Early recognition of the disease and beginning of 
appropriate treatment is crucial for the prevention 
of residual deformities. 
There are several approaches to the an-
ti-tubercular treatment. The use of non-steroi-
dal anti-inflammatory drugs is very limited, 
although in selected cases with early disease, 
they may prevent lesions caused by synovial 
inflammation. Most protocols include 2 months 
of HREZ followed by a continuation phase, and 
the duration of treatment is variable between 6, 
9, 12, and 18 months [1, 7]. The 2016 Index-TB 
guidelines on extrapulmonary tuberculosis in 
India of the World Health Organization Country 
Office for India recommend 2 months of HREZ 
and a continuation phase of 10 months that can 
be extended up to 18 months of treatment in total 
[9]. On the other hand, the United Kingdom NICE 
tuberculosis guidelines of 2016 suggest that pa-
tients with spinal TB should be treated with a six-
month regimen, unless there is direct spinal cord 
impairment, in which case the regimen should 
be prolonged to 12 months. In these patients, 
surgical debridement has not been shown to offer 
a clinical benefit over medical treatment, unless 
there is a poor response to medical treatment with 
persistence of infection, instability of the spine 
or evidence of spinal cord compression [10]. Due 
to the noteworthy differences in the duration of 
the treatment protocols, clinical judgement and 
expert opinion are irreplaceable for the manage-
ment of these patients.
Concerning the cases where chemotherapy 
alone is not sufficient, as for patients with cold 
abscesses, paraplegia, or spinal deformity, vari-
ous surgical procedures are used as an adjunct to 
the anti-tuberculous medical regimens. Abscess 
drainage may be performed in selected patients, 
although it is not recommended for routine prac-
tice as abscesses usually resolve with chemother-
apy alone. Focal debridement is also rarely indi-
cated, because it does not improve the outcome. 
Concerning tuberculous scoliosis, if surgical 
treatment is considered, posterior or anterior sta-
bilization after anterior corrective radical surgery 
is preferable. Corrective and stabilizing spinal 
surgery is the method of choice for active progres-
sive and nonrigid kyphosis, although surgery is 
not recommended in early disease, in which case 
conservative treatment alone is sufficient.
Paraplegia is another major concern, and its 
main causes are the compression of the spinal 
cord by an abscess or granulation tissue and bony 
canal stenosis of the deformed spine. Outcomes 
depend on several factors, including the patient’s 
performance status and the severity of deformity 
Table 2. Notifications of tuberculosis cases (all forms and extrapulmonary, new and relapse cases) globally and for World 
Health Organization regions 2018 [8]
Total notified New and relapse Extrapulmonary new and relapse [%]
Africa 1 402 743 1 372 748 15%
The Americas 248 135 233 549 15%
Eastern Mediterranean 537 761 526 379 24%
Europe 260 331 218 090 16%
South-East Asia 3 362 783 3 183 255 17%
Western Pacific 1 441 363 1 416 729 8%
Global 7 253 116 6 950 750 15%
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(for example kyphosis of over 60°C has a very poor 
prognosis). Decompression surgery is indicated in 
acute-onset rapidly progressive paralysis, as well 
as in the case of peridural fibrosis with chronic 
compression within the narrow canal. Neurolog-
ical recovery seems to be poorer in adults than 
in children [1].
Conclusions
Tuberculous spondylitis is an uncommon 
but potentially lethal manifestation of extratho-
racic tuberculosis. A thorough clinical evalua-
tion is required, as the disease can present with 
non-specific symptoms. The treatment should 
aim at the eradication of mycobacteria, as well as 
the prevention and correction of residual spinal 
deformities and neurological deficits. Chemo-
therapy of variable duration up to 18 months is 
currently the cornerstone of management, how-
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